VELLANKI AVANISH (President and CEO) reported 1 transaction at RAIN ONCOLOGY INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/27/2021ACC: 0000899243-21-017111
DirectorOfficer· President and CEO
Since Apr 2021
-896.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
11.21K acquired · 12.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.21K
Price / share
—
Trade value
—
% of position
0.5%
4/27/2021
2.36M→2.37M
Total
Net shares
+11.21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/27/2021 | C · Conversion | +11.21K | — | — | 0.5% | 2.36M | 2.37M |
| Total | +11.21K | $0.00 | ||||||
Derivative Transactions1
Series A Preferred Stock
Direct
Converts to
Common Stock
11.21K shares
Shares
−12.11K
Strike price
Held after
0.00
Exercisable
—
4/27/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock11.21K shares | 4/27/2021 | C · Conversion | −12.11K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned138.90K
Total
138.90K indirect138.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 138.90K | Indirect |
| Total | 138.90K | 138.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported